Anavex Life Sciences Corp (AVXL)

[georgejjl]

ANTICIPATION OF AVXL NEWS THIS WEEK!!!

Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled 48-week Safety and Efficacy Trial of ANAVEX2-73 for the Treatment of Early Alzheimer's Disease (AD)
Actual Study Start Date :
July 3, 2018
Estimated Primary Completion Date :
May 30, 2022
Estimated Study Completion Date :
June 30, 2022

https://clinicaltrials.gov/ct2/show/NCT03790709

****************************

Open Label Extension Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001
Actual Study Start Date :
October 10, 2019
Estimated Primary Completion Date :
April 2022
Estimated Study Completion Date :
June 2022

https://clinicaltrials.gov/ct2/show/NCT04575259

Good luck and GOD bless,